II. Indications
- 
                          Thionamide (Methimazole or Propylthiouracil) Indications- Hyperthyroidism in children and adolescents
- Hyperthyroidism in Pregnancy (first trimester for PTU, Methimazole after)
- Severe Grave's Disease (e.g. Thyroid Storm)
- Subclinical Hyperthyroidism
 
- Methimazole is the preferred first-line Thionamide (over PTU) in most cases due to lower hepatotoxicity
- Reasons to use Propylthiouracil (PTU) instead of Methimazole- Lactation
- Pregnancy (both PTU and Methimazole are Pregnancy Category D)- Use Propylthiouracil (PTU) in first trimester
- Use Methimazole in second and third trimester
 
 
III. Contraindications
- First Trimester pregnancy
IV. Mechanism
V. Medications
- Methimazole (Tapazole) 5 mg and 10 mg tablets
VI. Dosing: Adults with Hyperthyroidism
- Target dose to Free T4 high end of normal range
- Start- Subclinical Hyperthyroidism: 5 mg orally daily
- Mild Hyperthyroidism: 5 mg orally three times daily
- Moderate Hyperthyroidism: 10 mg orally three times daily
- Severe Hyperthyroidism: 20 mg orally three times daily
 
- Maintenance- Titrate Methimazole dose down after 4 to 6 weeks
- Reduce dose to 5-10 mg per day
- Goal: maintain normal Thyroid function
- Range: 5 to 30 mg/day
 
VII. Dosing: Children with Hyperthyroidism
VIII. Adverse effects (3 per 1000 patients)
- 
                          Drug-Induced Agranulocytosis (more common with PTU)- Risk increases over age 40 years
- Occurs in 0.17% of those on Methimazole
- Presentation: Infection (e.g. Pharyngitis)
- Obtain Complete Blood Count if suspected
- Course- Resolves within 2-3 weeks after drug stopped
- Severe, refractory course may occur
 
- Contraindication to further Antithyroid Drugs
 
- 
                          Jaundice
                          - Cholestatic Jaundice
- Occurs more commonly with Methimazole
 
- Hepatitis- Occurs with both Methimazole and Propylthiouracil (PTU)- However, PTU is higher risk of liver injury, making Methimazole preferred in most cases
 
- Methimazole associated hepatitis- Incidence: 3.17 per 1000 person-years
- Acute Hepatic Failure: 0.32 per 1000 person-years
 
- Propylthiouracil (PTU) is associated with severe liver injury- Adults: 1 in 10,000
- Children: 1 in 2,000
 
 
- Occurs with both Methimazole and Propylthiouracil (PTU)
- Vasculitis
- Lupus-Like Syndrome
- Aplastic Anemia
- Rash or Pruritus- Switch from PTU to Methimazole if severe
 
- Arthralgia or Polyarthritis
- Fever
- Congenital abnormalities possible with Methimazole
IX. Safety
- 
                          Lactation
                          - Considered safe in Lactation (preferred Thionamide over PTU)
 
- Pregnancy Category D (applies to both PTU and Methimazole)- Methimazole is preferred Thionamide in second and third trimester of pregnancy
- Methimazole is contraindicated in first trimester due to congenital defect risk- Esophageal atresia
- Choanal Atresia
- Aplasia cutis
- Abdominal wall defects
- Ventricular Septal Defect
 
 
X. Monitoring
- Repeat examination every 3 months
- Pregnancy Test before starting therapy
- Lab Testing while on antithyroid medications: Monthly for 6 to 12 months- Complete Blood Count (CBC)- Obtain at baseline
- Repeat if Pharyngitis or fever occur (need not be done without symptoms or signs)
 
- Liver Function Tests- Obtain at baseline and if symptoms develop
 
- Thyroid Function Tests (baseline, then every 4-8 weeks, then after stabilizing, every 3 months)- Thyroid Stimulating Hormone (TSH) after stabilizing, once on every 3 month schedule
- Free T4
- Free T3
 
 
- Complete Blood Count (CBC)
- Lab Testing after completing antithyroid medications- Obtain Thyroid Function Tests every 1-3 months for 6-12 months
 
- Indications to discontinue medication (via taper)- Total treatment course of 12-18 months AND
- TSH normalized for 6-12 months
 
- Indications to consider Thyroid ablation- Inadequate suppression at 12 months from initiation
 
XI. Efficacy
- Methimazole advantages over Propylthiouracil (PTU)- Once daily dosing
- Decreases T4 and T3 levels more rapidly
- Much safer than PTU- Lower risk of Agranulocytosis at moderate doses
- Does not carry the same liver toxicity risk as PTU
 
 
- Predictors of Relapse with Thionamides (occurs in 30-70% of cases within first year)- Tobacco Abuse
- Large Goiter
- Thyroid Stmulating Antibody high at end of treatment
 
XII. Resources
XIII. References
Images: Related links to external sites (from Bing)
Related Studies
| methimazole (on 12/21/2022 at Medicaid.Gov Survey of pharmacy drug pricing) | ||
| METHIMAZOLE 10 MG TABLET | Generic | $0.11 each | 
| METHIMAZOLE 5 MG TABLET | Generic | $0.06 each | 
